Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Invested Capital: 2024-2025

Historic Return on Invested Capital for OptimizeRx (OPRX) over the last 3 years, with Q3 2025 value amounting to 0.06%.

  • OptimizeRx's Return on Invested Capital rose 2700.0% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 2700.0%. This contributed to the annual value of 0.07% for FY2024, which is 600.0% up from last year.
  • As of Q3 2025, OptimizeRx's Return on Invested Capital stood at 0.06%, which was up 2700.0% from 0.01% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's Return on Invested Capital registered a high of 0.06% during Q3 2025, and its lowest value of 0.22% during Q3 2024.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.11% (2023), whereas its average is 0.1%.
  • As far as peak fluctuations go, OptimizeRx's Return on Invested Capital tumbled by -400bps in 2024, and later skyrocketed by 2700bps in 2025.
  • Over the past 3 years, OptimizeRx's Return on Invested Capital (Quarter) stood at 0.14% in 2023, then soared by 46bps to 0.07% in 2024, then soared by 177bps to 0.06% in 2025.
  • Its Return on Invested Capital stands at 0.06% for Q3 2025, versus 0.01% for Q2 2025 and 0.05% for Q1 2025.